Cold-chain requirements and the tight logistical windows needed for cell and gene therapies demand a focus on early communication and risk mitigation.
Brian Keesee
Advertisement
Brian Keesee is Executive Director for North America Operations, PCI Clinical Services.
Articles by Brian Keesee
Advertisement
Latest Updated Articles
Careful, Early Cold-Chain Planning is Crucial for New BiologicsPublished: February 1st 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
3
New Targets for Clinical Trials in the European Union
4
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two
5
